News from amakem A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

13 May, 2014, 11:13 BST Amakem Initiates Phase 2 Dose-Ranging Study for Locally-Acting ROCK Inhibitor AMA0076 in Glaucoma

Amakem Therapeutics, a clinical stage ophthalmology company, today announced that first patients have commenced treatment in a Phase 2 dose-ranging...


04 Mar, 2014, 09:00 GMT Amakem Appoints Dr. James Tsai of the Yale School of Medicine to its Clinical Advisory Board

Amakem Therapeutics, a clinical stage ophthalmology company, today announced the appointment of Dr. James Tsai to its Clinical Advisory Board. Dr....


07 Nov, 2013, 11:18 GMT Amakem to Present Top-Line Clinical Results for its Lead Candidate, AMA0076, at Ophthalmology Innovation Summit at the American Academy of Ophthalmology Meeting 2013

Amakem Therapeutics, a clinical stage ophthalmology company, today announces that Dr. Jack Elands, CEO, will present at the Ophthalmology Innovation...


24 Jun, 2013, 09:00 BST Amakem Appoints Kieran Rooney as Vice President, Business Development

Amakem NV, a clinical stage ophthalmology company, today announces that it has appointed Dr. Kieran Rooney as Vice President, Business Development....


03 Jun, 2013, 09:00 BST Amakem to Present at Jefferies Global Healthcare Conference

Amakem NV, a clinical stage ophthalmology company, today announces that Dr. Jack Elands, CEO, will present at the Jefferies 2013 Global Healthcare...


08 Apr, 2013, 09:33 BST Amakem Sponsors Ophthalmology Chair at KU Leuven

Amakem NV, a kinase platform company focusing on ophthalmology, today announces it has sponsored a new Chair of Ophthalmology Translational Research...


11 Jul, 2012, 09:00 BST Amakem Appoints Maarten van Geffen as Head of CMC and Operations

Amakem NV, a kinase platform company focusing on ophthalmology, today announces the appointment of Maarten van Geffen as Head of CMC and Operations....


08 May, 2012, 09:00 BST Amakem Presents AMA0076 Data at the 2012 ARVO Annual Meeting

Local ROCK Inhibition Highly Effective in Lowering IOP in Glaucoma Model While Avoiding Hyperemia Amakem NV, a kinase platform company focusing on...


20 Mar, 2012, 09:00 GMT Amakem Recruits Leading Ophthalmology Experts to Clinical Advisory Board

Amakem NV, a kinase platform company focusing on ophthalmology, today announced it has established a Clinical Advisory Board (CAB) with the...


02 Nov, 2011, 15:40 GMT Amakem Announces Further Proof-of-Concept Results for its 'Localized Drug Action' Platform

Kinase inhibitor reduces inflammation in the lungs in COPD model with no cardiovascular side effects Amakem NV, a kinase platform company focusing on ...